{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:32Z","timestamp":1786987052921,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clml.2021.01.009","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T16:06:45Z","timestamp":1610640405000},"page":"e506-e509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Symptomatic BK Virus Disease in Patients With Heavily Pretreated Multiple Myeloma"],"prefix":"10.1016","volume":"21","author":[{"given":"Eyal","family":"Lebel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-8810","authenticated-orcid":false,"given":"Rodger","family":"Tiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.01.009_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gfu023","article-title":"BK virus infection: an update on diagnosis and treatment","volume":"30","author":"Sawinski","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 1","key":"10.1016\/j.clml.2021.01.009_bib2","first-page":"S2","article-title":"BK and JC virus: a review","volume":"68","author":"Pinto","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.clml.2021.01.009_bib3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1099\/vir.0.18842-0","article-title":"Seroepidemiology of the human polyomaviruses","volume":"84","author":"Stolt","year":"2003","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.clml.2021.01.009_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2021.01.009_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/TP.0b013e31826690c6","article-title":"Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study","volume":"94","author":"Sood","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.clml.2021.01.009_bib6","first-page":"12","article-title":"ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.clml.2021.01.009_bib7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00277-016-2725-8","article-title":"A\u00a0case of BK virus nephropathy without hemorrhagic cystitis after hematopoietic stem cell transplantation","volume":"95","author":"Burbach","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.01.009_bib8","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V98.6.1971","article-title":"Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation","volume":"98","author":"Leung","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.009_bib9","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1128\/JCM.42.11.5394-5396.2004","article-title":"Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation","volume":"42","author":"Bogdanovic","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.clml.2021.01.009_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clml.2021.01.009_bib11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.bmt.1704944","article-title":"Polyoma BK viruria in patients undergoing autologous hematopoietic stem cell transplantation","volume":"35","author":"Leung","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.009_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM198607243150405","article-title":"Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants","volume":"315","author":"Arthur","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2021.01.009_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.clml.2021.01.009_bib14","doi-asserted-by":"crossref","first-page":"e2044","DOI":"10.1002\/rmv.2044","article-title":"BK virus: current understanding of pathogenicity and clinical disease in transplantation","volume":"29","author":"Chong","year":"2019","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.clml.2021.01.009_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.ajkd.2014.11.020","article-title":"Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation","volume":"65","author":"Papanicolaou","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clml.2021.01.009_bib16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcyt.2014.04.003","article-title":"Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation","volume":"16","author":"Mani","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.clml.2021.01.009_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.01.009_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bmt.1701376","article-title":"Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis","volume":"22","author":"Hughes","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.01.009_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ekir.2017.12.014","article-title":"Polyomavirus nephropathy in autologous stem cell transplantation","volume":"3","author":"Malavade","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.clml.2021.01.009_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/1535-7163.MCT-08-0664","article-title":"Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells","volume":"8","author":"Baumann","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clml.2021.01.009_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaoncol.2019.5098","article-title":"Listeria susceptibility in patients with multiple myeloma receiving daratumumab-based therapy","volume":"6","author":"Khan","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2021.01.009_bib22","doi-asserted-by":"crossref","first-page":"e0211927","DOI":"10.1371\/journal.pone.0211927","article-title":"Infectious complications and NK cell depletion following daratumumab treatment of multiple myeloma","volume":"14","author":"Nahi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2021.01.009_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.15433","article-title":"Infectious and immunological sequelae of daratumumab in multiple myeloma","volume":"185","author":"Johnsrud","year":"2019","journal-title":"Br J Haematol"},{"issue":"suppl 2","key":"10.1016\/j.clml.2021.01.009_bib24","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.cmi.2018.03.022","volume":"24","author":"Drgona","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:43Z","timestamp":1761870943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2152265021000100"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic BK Virus Disease in Patients With Heavily Pretreated Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}